Archive

Neovasc Provides Corporate Update

VANCOUVER and MINNEAPOLIS - (NewMediaWire) - August 13, 2020 - Neovasc, Inc.(NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), today provided a corporate update on progress towards its value creation strategies.Fred Colen, Chief Executive Officer of Neovasc, commented, "We are pleased to provide acorporate updateto...

Read More

Neovasc Announces Second Quarter Financial Results

NASDAQ, TSX: NVCN   VANCOUVER and MINNEAPOLIS, August 6, 2020 – Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, today reported financial results for...

Read More

Neovasc Reducer™ Featured In Germany’s Second Largest National Newspaper

NASDAQ, TSX: NVCN   VANCOUVER, CA, MINNEAPOLIS, US and FRANKFURT, DE, July 24, 2020 – Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that the Neovasc Reducer™ (the “Reducer”) was featured in a supplement titled: “Volkskrankheiten” or “Common Diseases”  in Frankfurter Allgemeine Zeitung (FAZ),...

Read More

Neovasc Announces Partial Prepayment of Convertible Debenture

NASDAQ, TSX: NVCN   VANCOUVER and MINNEAPOLIS, – July 23, 2020 – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that Strul Medical Group LLC (“SMG”) exercised 1,424,049 of the 2,573,959 common share purchase warrants (the “May Warrants”) issued pursuant to a Securities Purchase...

Read More

Neovasc Provides Update on Second Quarter Results

Company to Report Full Financial Results on August 6, 2020   NASDAQ, TSX: NVCN   VANCOUVER and MINNEAPOLIS, July 6, 2020 – Neovasc, Inc. (NASDAQ, TSX: NVCN), today announced preliminary revenue results for the second quarter of 2020. Revenue for the quarter ended June 30, 2020 was approximately $295,000. Revenues...

Read More